Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy
BACKGROUND: Recurrent hepatitis C (HCV) after liver transplantation (LT) is often more aggressive and treatments tend to be less successful. Pegylated-interferon and ribavirin are the standard of care for the treatment of HCV; however, there is limited published experience of its use after LT.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2005-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2005/745197 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549835679465472 |
|---|---|
| author | Mohamed Babatin Lynn Schindel Kelly W Burak |
| author_facet | Mohamed Babatin Lynn Schindel Kelly W Burak |
| author_sort | Mohamed Babatin |
| collection | DOAJ |
| description | BACKGROUND: Recurrent hepatitis C (HCV) after liver transplantation (LT) is often more aggressive and treatments tend to be less successful. Pegylated-interferon and ribavirin are the standard of care for the treatment of HCV; however, there is limited published experience of its use after LT. |
| format | Article |
| id | doaj-art-052a62b38b024ce6bd78aeadd952e06e |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2005-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-052a62b38b024ce6bd78aeadd952e06e2025-02-03T06:08:20ZengWileyCanadian Journal of Gastroenterology0835-79002005-01-0119635936510.1155/2005/745197Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for TherapyMohamed Babatin0Lynn Schindel1Kelly W Burak2University of Calgary Liver Unit, Calgary, Alberta, CanadaUniversity of Calgary Liver Unit, Calgary, Alberta, CanadaUniversity of Calgary Liver Unit, Calgary, Alberta, CanadaBACKGROUND: Recurrent hepatitis C (HCV) after liver transplantation (LT) is often more aggressive and treatments tend to be less successful. Pegylated-interferon and ribavirin are the standard of care for the treatment of HCV; however, there is limited published experience of its use after LT.http://dx.doi.org/10.1155/2005/745197 |
| spellingShingle | Mohamed Babatin Lynn Schindel Kelly W Burak Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy Canadian Journal of Gastroenterology |
| title | Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy |
| title_full | Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy |
| title_fullStr | Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy |
| title_full_unstemmed | Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy |
| title_short | Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy |
| title_sort | pegylated interferon alpha 2b and ribavirin for recurrent hepatitis c after liver transplantation from a canadian experience to recommendations for therapy |
| url | http://dx.doi.org/10.1155/2005/745197 |
| work_keys_str_mv | AT mohamedbabatin pegylatedinterferonalpha2bandribavirinforrecurrenthepatitiscafterlivertransplantationfromacanadianexperiencetorecommendationsfortherapy AT lynnschindel pegylatedinterferonalpha2bandribavirinforrecurrenthepatitiscafterlivertransplantationfromacanadianexperiencetorecommendationsfortherapy AT kellywburak pegylatedinterferonalpha2bandribavirinforrecurrenthepatitiscafterlivertransplantationfromacanadianexperiencetorecommendationsfortherapy |